Чланци са овлашћеним јавним приступом - Piersante SestiniСазнајте више
Није доступно нигде: 2
The innervation of mast cells
RH Stead, MH Perdue, MG Blennerhassett, Y Kakuta, P Sestini, ...
The Neuroendocrine Immune Network, 19-37, 2018
Овлашћења: Canadian Institutes of Health Research
Pulmonary lymphatic vessel morphology: a review
E Weber, F Sozio, A Borghini, P Sestini, E Renzoni
Annals of Anatomy-Anatomischer Anzeiger 218, 110-117, 2018
Овлашћења: Versus Arthritis, UK
Доступно негде: 15
Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis
A De Lauretis, P Sestini, P Pantelidis, R Hoyles, DM Hansell, NSL Goh, ...
The Journal of rheumatology 40 (4), 435-446, 2013
Овлашћења: Versus Arthritis, UK
A polymorphism in the CTGF promoter region associated with systemic sclerosis
C Fonseca, GE Lindahl, M Ponticos, P Sestini, EA Renzoni, AM Holmes, ...
New England Journal of Medicine 357 (12), 1210-1220, 2007
Овлашћења: Versus Arthritis, UK, British Heart Foundation
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial
D Visca, L Mori, V Tsipouri, S Fleming, A Firouzi, M Bonini, MJ Pavitt, ...
The Lancet Respiratory Medicine 6 (10), 759-770, 2018
Овлашћења: Versus Arthritis, UK, National Institute for Health Research, UK
Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease
GE Lindahl, CJW Stock, X Shi-Wen, P Leoni, P Sestini, SL Howat, ...
Respiratory research 14, 1-14, 2013
Овлашћења: Versus Arthritis, UK
Pathogenesis of idiopathic pulmonary fibrosis: review of recent findings
E Renzoni, V Srihari, P Sestini
F1000prime reports 6, 69, 2014
Овлашћења: National Institute for Health Research, UK
Serum markers of pulmonary epithelial damage in systemic sclerosis‐associated interstitial lung disease and disease progression
CJW Stock, RK Hoyles, C Daccord, M Kokosi, D Visca, A De Lauretis, ...
Respirology 26 (5), 461-468, 2021
Овлашћења: Versus Arthritis, UK, National Institute for Health Research, UK
Lymphatic and blood vessels in scleroderma skin, a morphometric analysis
A Rossi, F Sozio, P Sestini, EA Renzoni, K Khan, CP Denton, DJ Abraham, ...
Human pathology 41 (3), 366-374, 2010
Овлашћења: Versus Arthritis, UK
Mucins MUC5B and MUC5AC in distal airways and honeycomb spaces: comparison among idiopathic pulmonary fibrosis/usual interstitial pneumonia, fibrotic nonspecific interstitial …
C Conti, A Montero-Fernandez, E Borg, T Osadolor, P Viola, A De Lauretis, ...
American journal of respiratory and critical care medicine 193 (4), 462-464, 2016
Овлашћења: US National Institutes of Health, US Department of Veterans Affairs, Versus …
Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease
V Alfieri, E Crisafulli, D Visca, WH Chong, C Stock, L Mori, A de Lauretis, ...
European Respiratory Journal 55 (2), 2020
Овлашћења: Versus Arthritis, UK
Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial
D Visca, V Tsipouri, L Mori, A Firouzi, S Fleming, M Farquhar, E Leung, ...
Trials 18, 1-11, 2017
Овлашћења: Versus Arthritis, UK, National Institute for Health Research, UK
Cytomegalovirus infection is associated with development of chronic lung allograft dysfunction
D Bennett, L Bergantini, P Ferrara, MG Cusi, S Scolletta, F Montagnani, ...
Lung 200 (4), 513-522, 2022
Овлашћења: Government of Italy
Serum C‐reactive protein is associated with earlier mortality across different interstitial lung diseases
CJW Stock, WG Bray, V Kouranos, J Jacob, M Kokosi, PM George, ...
Respirology 29 (3), 228-234, 2024
Овлашћења: Versus Arthritis, UK
Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide
M Villano, A Borghini, M Manetti, E Gabbrielli, A Rossi, P Sestini, AF Milia, ...
Arthritis Research & Therapy 15, 1-12, 2013
Овлашћења: Government of Italy
Interaction between the promoter MUC5B polymorphism and mucin expression: is there a difference according to ILD subtype?
CJ Stock, C Conti, Á Montero-Fernandez, G Caramori, PL Molyneaux, ...
Thorax 75 (10), 901-903, 2020
Овлашћења: Versus Arthritis, UK
Cost-effectiveness of ambulatory oxygen in improving quality of life in fibrotic lung disease: preliminary evidence from the AmbOx Trial
JA Whitty, J Rankin, D Visca, V Tsipouri, L Mori, L Spencer, H Adamali, ...
European Respiratory Journal 55 (2), 2020
Овлашћења: Versus Arthritis, UK, National Institute for Health Research, UK
Публикације и информације о финансирању аутоматски одређује рачунарски програм